Setting 
My Cart
Toggle Nav
mobile icon
Close
  • Menu
  • Setting

Bioactive Compounds

Items 11221-11230 of 13618

Page
per page
  1. NVP-BGJ398 phosphate
    A3673 NVP-BGJ398 phosphate
    Summary: FGFR inhibitor
      insoluble in EtOH; ≥28.07 mg/mL
  2. NVP-BSK805
    A3675 NVP-BSK805
    Summary: ATP-competitive JAK2 inhibitor
      ≥20.95 mg/mL
  3. Saquinavir
    A3790 Saquinavir
     1 Citation
    Summary: HIV Protease Inhibitor
      Soluble in DMSO
  4. SCH 563705
    A3803 SCH 563705
    Target: CXCR
    Summary: CXCR2/CXCR1 antagonist,potent
      Soluble in DMSO
  5. Setiptiline
    A3815 Setiptiline
    Summary: Serotonin receptor antagonist
      ≥15.43 mg/mL
  6. SLx-2119
    A3825 SLx-2119
     1 Citation
    Target: ROCK
    Summary: Selective ROCK2 inhibitor
      ≥22.65 mg/mL
  7. Toceranib
    A3879 Toceranib
    Summary: c-Kit/VEGFR/PDGFR inhibtor
      ≥2.8 mg/mL
  8. Toremifene
    A3884 Toremifene
    Summary: Estrogen-receptor modulator
      ≥12.38 mg/mL
  9. CCT020312
    BA3586 CCT020312
    Summary: CCT020312 is a selective activator.
  10. Mertansine
    BA2321 Mertansine
    Summary: A maytansinoid microtubule inhibitor that can be conjugated to monoclonal antibodies for antibody-drug conjugates (ADC)
      ≥26.65 mg/mL

Items 11221-11230 of 13618

Page
per page